Exact FDA event identifier

Event 68342

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: April 19, 2013
Product types: Drug
Classifications: Class I
Statuses: Terminated
Recalling firm wording: Abrams Royal Pharmacy

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL, supplied in 11 mL Sterile Syringes, Rx only, Compounded med, Single use only, (Red Block) ABRAMS ROYAL Compounding Pharmacy, Dallas, TX

D-0251-2015

Recall number: D-0251-2015
Initiated: April 19, 2013
Classification: Class I
Status: Terminated
Recalling firm: Abrams Royal Pharmacy
Quantity: 50 syringes

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0

Non-Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility

Code information

Lot# 041013-13 (also been written as "041013@13") Exp: 06/09/2013

Distribution pattern

Texas